1. Short title This Act may be cited as the Right Drug Dose Now Act of 2024 . 2. Table of contents The table of contents of this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. Sec. 3. National Action Plan for Adverse Drug Event Prevention. Sec. 4. Adverse drug event and pharmacogenomic testing education for health care professionals. Sec. 5. Improving EHR systems to improve the use of pharmacogenomic information. 3. National Action Plan for Adverse Drug Event Prevention The Secretary of Health and Human Services (in this Act referred to as the Secretary ) shall— (1) not later than 180 days after the date of enactment of this Act, in coordination with the heads of other relevant Federal departments and agencies, submit a report to the Congress on the implementation of the National Action Plan for Adverse Drug Event Prevention of the Department of Health and Human Services, including on the progress in meeting the target outcomes approved by the Federal Interagency Steering Committee for Adverse Drug Events; (2) convene the Federal Interagency Steering Committee for Adverse Drug Events to update the National Action Plan for Adverse Drug Event Prevention; and (3) require such Committee, in updating the National Action Plan for Adverse Drug Event Prevention— (A) to consider advances in scientific understanding and technology pertaining to drug-gene interactions (including interactions among multiple drugs and genes), clinical outcomes, health care utilization, and the decreasing cost of genetic testing; (B) to assess the role of pharmacogenetics testing combined with clinical decision support as an evidence-based prevention tool